Cargando…

Scleroderma-specific autoantibodies embedded in immune complexes mediate endothelial damage: an early event in the pathogenesis of systemic sclerosis

BACKGROUND: Consistently with their diagnostic and prognostic value, autoantibodies specific for systemic sclerosis (SSc) embedded in immune complexes (ICs) elicited a pro-inflammatory and pro-fibrotic cascade in healthy skin fibroblasts, engaging Toll-like receptors (TLRs) via their nucleic acid co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Raschi, Elena, Privitera, Daniela, Bodio, Caterina, Lonati, Paola Adele, Borghi, Maria Orietta, Ingegnoli, Francesca, Meroni, Pier Luigi, Chighizola, Cecilia Beatrice
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7654597/ https://www.ncbi.nlm.nih.gov/pubmed/33168071 http://dx.doi.org/10.1186/s13075-020-02360-3

Ejemplares similares

Immune complexes containing scleroderma-specific autoantibodies induce a profibrotic and proinflammatory phenotype in skin fibroblasts
por: Raschi, Elena, et al.
Publicado: (2018)

Pathogenic Role of Complement in Antiphospholipid Syndrome and Therapeutic Implications
por: Tedesco, Francesco, et al.
Publicado: (2018)

Anti-Phospholipid Antibodies and Coronavirus Disease 2019: Vaccination Does Not Trigger Early Autoantibody Production in Healthcare Workers
por: Borghi, Maria Orietta, et al.
Publicado: (2022)

The IMMENSE Study: The Interplay Between iMMune and ENdothelial Cells in Mediating Cardiovascular Risk in Systemic Lupus Erythematosus
por: Bortoluzzi, Alessandra, et al.
Publicado: (2020)

The Complement System in the Pathophysiology of Pregnancy and in Systemic Autoimmune Rheumatic Diseases During Pregnancy
por: Chighizola, Cecilia Beatrice, et al.
Publicado: (2020)

Association of anti-RNA polymerase III autoantibodies and cancer in scleroderma
por: Moinzadeh, Pia, et al.
Publicado: (2014)

Beyond Systemic Lupus Erythematosus and Anti-Phospholipid Syndrome: The Relevance of Complement From Pathogenesis to Pregnancy Outcome in Other Systemic Rheumatologic Diseases
por: Cavalli, Silvia, et al.
Publicado: (2022)

Production of anti-PF4 antibodies in antiphospholipid antibody-positive patients is not affected by COVID-19 vaccination
por: Lonati, Paola Adele, et al.
Publicado: (2022)

Automated tests of ANA immunofluorescence as throughput autoantibody detection technology: strengths and limitations
por: Meroni, Pier Luigi, et al.
Publicado: (2014)

The clinical relevance of autoantibodies in scleroderma
por: Ho, Khanh T, et al.
Publicado: (2003)

Treatment of Thrombotic Antiphospholipid Syndrome: The Rationale of Current Management—An Insight into Future Approaches
por: Chighizola, Cecilia Beatrice, et al.
Publicado: (2015)

Antiphospholipid syndrome in 2014: more clinical manifestations, novel pathogenic players and emerging biomarkers
por: Meroni, Pier Luigi, et al.
Publicado: (2014)

Clinical phenotype in scleroderma patients based on autoantibodies
por: Santos, Cristiana Sieiro, et al.
Publicado: (2023)

Pediatric Antiphospholipid Syndrome: from Pathogenesis to Clinical Management
por: Rosina, Silvia, et al.
Publicado: (2021)

Systemic Sclerosis: Scleroderma
por: Denman, A. M.
Publicado: (1989)

Effect of the JAK/STAT Inhibitor Tofacitinib on Macrophage Cholesterol Metabolism
por: Adorni, Maria Pia, et al.
Publicado: (2023)

Antiphospholipid antibodies detected by line immunoassay differentiate among patients with antiphospholipid syndrome, with infections and asymptomatic carriers
por: Roggenbuck, Dirk, et al.
Publicado: (2016)

β2 glycoprotein I participates in phagocytosis of apoptotic neurons and in vascular injury in experimental brain stroke
por: Grossi, Claudia, et al.
Publicado: (2021)

Antiphospholipid Antibody Assays in 2021: Looking for a Predictive Value in Addition to a Diagnostic One
por: Meroni, Pier Luigi, et al.
Publicado: (2021)

Investigation of myositis and scleroderma specific autoantibodies in patients with lung cancer
por: Betteridge, Zoe E., et al.
Publicado: (2018)

Combinations of scleroderma hallmark autoantibodies associate with distinct clinical phenotypes
por: Clark, Kristina E. N., et al.
Publicado: (2022)

Blood Cell-Bound C4d as a Marker of Complement Activation in Patients With the Antiphospholipid Syndrome
por: Lonati, Paola Adele, et al.
Publicado: (2019)

Vascular involvement in systemic sclerosis (scleroderma)
por: Pattanaik, Debendra, et al.
Publicado: (2011)

Systemic sclerosis (scleroderma): remaining challenges
por: Connolly, Mary Karin
Publicado: (2021)

Emerging treatments for scleroderma/systemic sclerosis
por: Zhu, Jane L, et al.
Publicado: (2021)

Systemic sclerosis sine scleroderma in children
por: Zulian, Francesco, et al.
Publicado: (2021)

Oxidative stress in the pathogenesis of systemic scleroderma: An overview
por: Vona, Rosa, et al.
Publicado: (2018)

Uniphasic Blanching of the Fingers, Abnormal Capillaroscopy in Nonsymptomatic Digits, and Autoantibodies: Expanding Options to Increase the Level of Suspicion of Connective Tissue Diseases beyond the Classification of Raynaud's Phenomenon
por: Ingegnoli, Francesca, et al.
Publicado: (2015)

Prevalence and Clinical Implications of Scleroderma-Specific Autoantibodies in Seronegative Patients with Sicca Complaints
por: Marketos, Nikolaos, et al.
Publicado: (2023)

New insight into antiphospholipid syndrome: antibodies to β2glycoprotein I-domain 5 fail to induce thrombi in rats
por: Durigutto, Paolo, et al.
Publicado: (2019)

Update on the pathogenesis of Scleroderma: focus on circulating progenitor cells
por: Brunasso, Alexandra Maria Giovanna, et al.
Publicado: (2016)

The Role of B Cells in Scleroderma Lung Disease Pathogenesis
por: Liossis, Stamatis-Nick C., et al.
Publicado: (2022)

Complement activation predicts negative outcomes in COVID-19: The experience from Northen Italian patients.
por: Meroni, Pier Luigi, et al.
Publicado: (2023)

Scleroderma with Nodular Scleroderma
por: Srisuttiyakorn, Chutika, et al.
Publicado: (2016)

What autoantibody tests should become widely available to help scleroderma diagnosis and management?
por: Muro, Yoshinao, et al.
Publicado: (2013)

Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cells
por: Gilbane, Adrian J, et al.
Publicado: (2013)

Systemic sclerosis medications and risk of scleroderma renal crisis
por: Gordon, S. M., et al.
Publicado: (2019)

Juvenile Idiopathic Arthritis, Uveitis and Multiple Sclerosis: Description of Two Patients and Literature Review
por: Chighizola, Cecilia Beatrice, et al.
Publicado: (2022)

Autoantibodies in Systemic Autoimmune Disorders
por: Mahler, Michael, et al.
Publicado: (2014)

Endothelial injury in scleroderma
Publicado: (1979)

Cannot write session to /tmp/vufind_sessions/sess_81clt4jg647940m6n16k1p9le0